Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (QoQ) (2012 - 2026)
Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.78% |
| Dec 31, 2025 | -85.36% |
| Sep 30, 2025 | -819.13% |
| Jun 30, 2025 | 98.50% |
| Mar 31, 2025 | -82.83% |
| Dec 31, 2024 | 14.72% |
| Sep 30, 2024 | -1,182.06% |
| Jun 30, 2024 | 30.22% |
| Mar 31, 2024 | 89.88% |
| Dec 31, 2023 | -100.33% |
| Sep 30, 2023 | 16,978.74% |
| Jun 30, 2022 | 29.96% |
| Mar 31, 2022 | -30.30% |
| Dec 31, 2021 | 72.81% |
| Sep 30, 2021 | 39.96% |
| Jun 30, 2021 | -90.29% |
| Mar 31, 2021 | -33.00% |
| Dec 31, 2020 | -106.53% |
| Sep 30, 2020 | 1,586.72% |
| Jun 30, 2020 | -114.90% |